'Antithrombotic therapy' diaporamas de présentation

COMPREHENSIVE META-ANALYSIS ON ORAL ANTICOAGULANTS FOR THE SECONDARY PREVENTION OF CORONARY ARTERY DISEASE INCLUDING MOR

COMPREHENSIVE META-ANALYSIS ON ORAL ANTICOAGULANTS FOR THE SECONDARY PREVENTION OF CORONARY ARTERY DISEASE INCLUDING MORE THAN 50,000 PATIENTS.

590 views • 43 slides

Eric L. Bonno, MD Alfred Buxton, MD Beth Israel Deaconess Medical Center January 12, 2012

Validation of Clinical Classification Schemes for Predicting Stroke Results From the National Registry of Atrial Fibrillation Gage et. al. JAMA 2001; 285(22). Eric L. Bonno, MD Alfred Buxton, MD Beth Israel Deaconess Medical Center January 12, 2012. In plain English.........

516 views • 42 slides

Advancements In Anticoagulation

615 views • 42 slides

Blood Management in the Cath Lab

Blood Management in the Cath Lab. Sunil V. Rao MD Associate Professor of Medicine Duke University Medical Center Durham VA Medical Center Duke Clinical Research Institute. Disclosures. Consultant Sanofi-Aventis, Bristol Myers Squibb The Medicines Company Astra Zeneca

745 views • 42 slides

Health eDecisions Pilots

556 views • 41 slides

ER Direct Case: Management of Atrial Fibrillation and Post-Treatment Bleeding in Patient with Prior TIA

ACS and Thrombosis in the Emergency Setting. ER Direct Case: Management of Atrial Fibrillation and Post-Treatment Bleeding in Patient with Prior TIA. Faculty/Presenter Disclosure. Faculty : Andre Douen, MD,PhD,FRCPC,FAHA Relationships with commercial interests:

631 views • 40 slides

662 views • 40 slides

IN THE NAME OF GOD

IN THE NAME OF GOD. SMALL FOR GESTATIONAL AGE . CASE 1. 27years G1 GA : 28w 2d (by sono 8w :28w 3d ) Fondal height : 24 cm. Sono 3 days ago. BPD :24W 3D AC : 22 W FL : 21 W AFI : NL Severe IUGR BPP: breath:0 AF:2 tone:2 Doppler : increased Umbilical artery RI.

565 views • 40 slides

Compliance With Anticoagulants

Compliance With Anticoagulants. Terminology and Definitions. ROCKET AF: Patients Off Study Drug Are at Increased Risk of Stroke and Non-CNS Embolism. Slight Benefit in First Year Post-Trial: No Harm or Benefit Years 2-5+. Features of NOACs. Dosing C onsiderations: Summary.

491 views • 36 slides

Victor C. Urrutia, MD, FAHA Assistant Professor Director, The Johns Hopkins Hospital Stroke Center

Sickle Cell Disease and Stroke. Victor C. Urrutia, MD, FAHA Assistant Professor Director, The Johns Hopkins Hospital Stroke Center Department of Neurology Johns Hopkins University School of Medicine vurruti1@jhmi.edu. Objectives. Review risk of stroke in the sickle cell disease population

484 views • 25 slides

What interventions should be considered in the prevention of SGA fetuses

407 views • 24 slides

407 views • 21 slides

HSN Stroke Prevention Clinic

HSN Stroke Prevention Clinic. What is a Secondary Stroke Prevention Clinic. Out-patient hospital-based clinic Provides an individualized, interdisciplinary, evidence-based approach to stroke prevention for those individuals at high risk of stroke to reduce stroke risk

426 views • 19 slides

Fibrillazione atriale

ASL PROVINCIA DI BERGAMO La gestione del paziente in Terapia Anticoagulante Orale (TAO). Fibrillazione atriale. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest . 2008 Jun ;133(6 Suppl ):.

333 views • 17 slides

Fibrillazione atriale

ASL PROVINCIA DI BERGAMO La gestione del paziente in Terapia Anticoagulante Orale (TAO). Fibrillazione atriale. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest . 2008 Jun ;133(6 Suppl ):.

340 views • 17 slides

Treatment of Acute Pulmonary Embolism

Treatment of Acute Pulmonary Embolism. Kevin Pham May 2014. Objective. T o review the management of acute pulmonary embolism. Case.

429 views • 17 slides

Is an Antithrombotic Therapy necessary after Mitral Valve Repair ?

Is an Antithrombotic Therapy necessary after Mitral Valve Repair ?. Ph Meurin, JY Tabet, MC Iliou, B Pierre, S Corone et A Bendriss, On behalf of the Working group of Cardiac Rehabilitation of the French Society of Cardiology. Absence of Financial Disclosure. Background.

557 views • 16 slides

Antithrombotic therapy in non-valvular AF patients

Rohan Subasinghe. Antithrombotic therapy in non-valvular AF patients. Why is it important?. Non valvular aF increases with age from 0.5 % at age 50-59 to 9 % at age 80-89 AF is an independent Risk factor for CVA Patients with AF have a 5 fold mean increase in Stroke due to atrial thrombosis.

244 views • 12 slides

A fib and Antithrombotic Therapy Cases

A fib and Antithrombotic Therapy Cases. Angie Pegram, PharmD , BCPS, CDE March 7, 2013. Case # 1.

260 views • 10 slides

Atrial Fibrillation (Management of Patients with)

Atrial Fibrillation (Management of Patients with). Joint ESC/ACC/AHA Guidelines 2006 Developed in collaboration with the European Heart Rhythm Association (EHRA) and the Heart Rhythm Society (HRS). Atrial Fibrillation.

591 views • 10 slides